Skip to Content

'
Stephen F. Kry, Ph.D.

Present Title & Affiliation

Primary Appointment

Assistant Professor, Department of Radiation Physics, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

Dual/Joint/Adjunct Appointment

Member, Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, TX

Bio Statement

 

My long-term professional goal is to improve the safety and efficacy of radiotherapy treatment for cancer patients by improving the quality and consistency of such treatments. The proposed project works directly towards this goal by ensuring consistent and quality radiotherapy is delivered to patients enrolled in clinical trials. This will have immediate benefit to those specific patients on clinical trial, and will benefit all patients in the long-term by ensuring that clinical trials generate the optimal results. I am well suited to be a co-investigator on this grant because I have substantial experience in evaluating doses delivered in a radiotherapy setting. This includes clinical experience, working with a wide range of radiotherapy patients undergoing contemporary radiotherapy. It also includes research in patient dosimetry, patient setup, and institution credentialing for clinical trials. Through these experiences I have a solid understanding of radiotherapy as it is currently practiced, the limitations of current practice, and what is necessary to ensure consistent, quality, treatments.

Education & Training

Degree-Granting Education

2007 The University of Texas MD Anderson Cancer Center, Houston, TX, PHD, Medical Physics
2003 The University of Texas MD Anderson Cancer Center, Houston, TX, MS, Medical Physics
1999 University of British Columbia, Vancouver, Canada, B.Sc., Honors Physics

Experience/Service

Academic Appointments

Instructor, Department of Radiation Physics, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2007-2010
Associate Member, Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, TX, 2007-2010
Graduate Research Assistant, Department of Radiation Physics, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2000-2007

Other Appointments/Responsibilities

Chair, White paper task group, Absolute dose calibration: dose to water or dose to muscle, American Association of Physicists in Medicine, College Park, MD, 2015-present
Chair, Work group on Radiation Dosimetry, American Association of Physicists in Medicine, College Park, MD, 2012-present
Member, TG-244: Minimum practice guideline, Commissioning and QA of TPS in external beam radiotherapy, American Association of Physicists in Medicine, College Park, MD, 2012-present
Chair, TG-158: Measurements and Calculations of out of field doses from external beam radiotherapy, American Association of Physicists in Medicine, College Park, MD, 2011-present
Member, Radiation Safety Subcommittee, American Associations of Physicists in Medicine, College Park, MD, 2011-present
Member, TG-219: Independent dose and MU verification for IMRT patient specific quality assurance, American Association of Physicists in Medicine, College Park, MD, 2011-present
Member, Work Group on Radiation Dosimetry, American Association of Physicists in Medicine, College Park, MD, 2010-present
Member, TG-203: Management of radiotherapy patients with implanted cardiac pacemakers and defibrillators, American Association of Physicists in Medicine, College Park, MD, 2010-present
Chair, TG-191: Recommendations on the use of luminescent dosimeters, American Association of Physicists in Medicine, College Park, MD, 2009-present
Member, Radiation Detection & Treatment Planning subcommittee, American Association of Physicists in Medicine, College Park, MD, 2009-present
Member, TG-159: Ethics Curriculum for Medical Physics Graduate Education, American Association of Physicists in Medicine, College Park, MD, 2007-2010
Member, Education and Training of Medical Physicists Committee, American Association of Physicists in Medicine, College Park, MD, 2006-2009
Member, Student Physicist Subcommittee, American Association of Physicists in Medicine, College Park, MD, 2006-2008
Chair, Student Physicist Subcommittee, American Association of Physicists in Medicine, College Park, MD, 2006-2007

Consultantships

Consultant for "Development of a training package for medical physics audits in radiotherapy", International Atomic Energy Agency, Vienna, Austria, 2015
Consultant for "Dosimetry audit methodology for advanced radiotherapy" project, International Atomic Energy Agency, Vienna, Austria, 2014
Consultant for "Database of IAEA quality audit results" project, International Atomic Energy Agency, United Nations, Vienna, Austria, 2014
Consultant for "Dosimetry audit methodology for advanced radiotherapy" project, International Atomic Energy Agency, United Nations, Vienna, Austria, 2013
Consultant for "DIRAC: Directory of Radiotherapy Centres" project, International Atomic Energy Agency, United Nations, Vienna, Austria, 2012

Institutional Committee Activities

Member, MD Anderson Faculty Academic Review Committee (FARC), 2015-present
Member, Medical Physics Ad Hoc Curriculum review committee, 2014-present
Member, Graduate School of Biomedical Sciences, Executive Committee, 2014-present
Member, Graduate School of Biomedical Sciences, Curriculum Committee, 2012-present
Member, Medical Physics Program Steering Committee, 2007-present

Honors and Awards

2014 "Institutional patient-specific IMRT QA does not predict unacceptable plan delivery" featured in the ESTRO Newsletter as an article of interest and "very high quality"

Selected Publications

Peer-Reviewed Original Research Articles

1. Scarboro SB, Cody D, Alvarez P, Followill D, Court L, Stingo FC, Zhang D, McNitt-Gray M, Kry SF. Characterization of the nanoDot OSLD dosimeter in CT. Med Phys 42(4):1797-807, 4/2015. PMCID: PMC4368592.
2. Huang JY, Kerns JR, Nute JL, Liu X, Balter PA, Stingo FC, Followill DS, Mirkovic D, Howell RM, Kry SF. An evaluation of three commercially available metal artifact reduction methods for CT imaging. Phys Med Biol 60(3). e-Pub 1/2015. PMID: 25585685.
3. Smilowitz JB, Das IJ, Feygelman V, Fraass BA, Kry SF, Marchall IR, Mihailidis D, Ouhib Z, Ritter T, Snyder MG, Fairobent L. AAPM Medical Physics Practice Guideline 5.a. Commissioning and QA of Treatment planning dose calculations, megavoltage photon and electron beams. J Appl Clin Med Phys 15(5). e-Pub 2015.
4. Xiao Y, Kry SF, Popple R, Yorke E, Papanikolaou N, Stathakis S, Xia P, Huq S, Bayouth J, Galvin J, Yin FF. Flattening filter-free accelerators: a report from the AAPM Therapy Emerging Technology Assessment Work Group. J Appl Clin Med Phys 16(3). e-Pub 2015.
5. McKenzie EM, Balter PA, Stingo FC, Jones J, Followill DS, Kry SF. Toward optimizing patient-specific IMRT QA techniques in the accurate detection of dosimetrically acceptable and unacceptable patient plans. Med Phys 41(12):121702, 12/2014. PMCID: PMC4235651.
6. Kry SF, Molineu A, Kerns JR, Faught AM, Huang JY, Pulliam KB, Tonigan J, Alvarez P, Stingo F, Followill DS. Institutional Patient-specific IMRT QA Does Not Predict Unacceptable Plan Delivery. Int J Radiat Oncol Biol Phys 90(5). e-Pub 10/2014. PMID: 25442044.
7. McKenzie EM, Balter PA, Stingo FC, Jones J, Followill DS, Kry SF. *Reproducibility in patient-specific IMRT QA. J Appl Clin Med Phys 15(3):4741, 2014. e-Pub 5/2014. PMCID: PMC4048867.
8. Kerns JR, Childress NL, Kry SF. A multi-institution evaluation of MLC performance. Radiation Oncology 9:176, 2014. e-Pub 2014.
9. Pulliam KB, Followill D, Court L, Dong L, Gillin M, Prado K, Kry SF. A six-year review of more than 13,000 patient-specific IMRT QA results from 13 different treatment sites. J Appl Clin Med Phys 15(5):196-206, 2014. e-Pub 9/2014. PMID: 25207581.
10. Huang JY, Pulliam KB, McKenzie EM, Followill DS, Kry SF. Effects of spatial resolution and noise on gamma analysis for IMRT QA. J Appl Clin Med Phys 15(4):4690, 2014. e-Pub 7/2014. PMID: 25207399.
11. Huang JY, Eklund D, Childress NL, Howell RM, Mirkovic D, Followill DS, Kry SF. Investigation of various energy deposition kernel refinements for the convolution superposition method. Med Phys 40(12):121721, 12/2013. PMCID: PMC3856653.
12. Kry SF, Alvarez P, Molineu A, Amador C, Galvin J, Followill DS. Algorithms used in heterogeneous dose calculations show systematic differences as measured in the Radiological Physics Centers' anthropomorphic thorax phantom used for RTOG credentialing. Int J Radiat Ocol Biol Phys 85(1). e-Pub 2013.
13. Hunter L, Kraft S, Choi H, Kry SF, Stingo F, Martel M, Court LE. High quality machine-robust image features: identification in non-small cell lung cancer computed tomography images. Med Phys 40(121). e-Pub 2013.
14. Kry SF, Jones J, Childress NL. Implementation and evaluation of an end-to-end IGRT test. J Appl Clin Med Phys 13(5):3939, 2012. e-Pub 9/2012. PMID: 22955659.
15. Kry SF, Popple R, Molineu A, Followill DS. Ion recombination correction factors (Pion) for Varian TrueBeam high-dose-rate therapy beams. J Appl Clin Med Phys 13(6):3803, 2012. e-Pub 11/2012. PMID: 23149774.
16. Followill DS, Kry SF, Qin L, Lowenstein J, Molineu A, Alvarez P, Aguirre JF, Ibbott GS. The Radiological Physics Center's standard dataset for small field size output factors. J Appl Clin Med Phys 13(5):3962, 2012. e-Pub 8/8/2012. PMID: 22955664.
17. Beyer GP, Kry SF, Espenhahn E, Rini C, Boyles E, Mann G. Evaluation of an implantable MOSFET dosimeter designed for use with hypo-fractionated external beam treatments and its applications for breast and prostate treatments. Med Phys 38(8):4881-4887, 8/2011. PMID: 21928659.
18. Kerns JR, Kry SF, Sahoo N, Followill DS, Ibbott GS. Angular dependence of the nanoDot OSL dosimeter. Med Phys 38(7):3955-62, 7/2011. PMCID: PMC3133805.
19. Scarboro SB, Followill DS, Howell RM, Kry SF. Variations in photon energy spectra of a 6 MV beam and their impact on TLD response. Med Phys 38(5):2619-2628, 5/2011. PMCID: PMC3107829.
20. Berrington de Gonzalez A, Curtis RE, Kry SF, Gilbert E, Lamart S, Berg CD, Stovall M, Ron E. Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries. Lancet Oncol 12(4):353-60, 4/2011. PMCID: PMC3086738.
21. Kry SF, Johnson JL, White RA, Howell RM, Kudchadker RJ, Gillin MT. Neutron-induced electronic failures around a high-energy linear accelerator. Med Phys 38(1):34-9, 1/2011. PMID: 21361172.
22. Howell RM, Scarboro SB, Kry SF, Yaldo DZ. Accuracy of out-of-field dose calculations by a commercial treatment planning system. Phys Med Biol 55(23):6999-7008, 12/7/2010. e-Pub 11/12/2010. PMCID: PMC3152254.
23. Scarboro SB, Stovall M, White A, Smith SA, Yaldo D, Kry SF, Howell RM. Effect of organ size and position on out-of-field dose distributions during radiation therapy. Phys Med Biol 55(23):7025-7036, 12/7/2010. e-Pub 11/12/2010. PMCID: PMC3152250.
24. Howell RM, Scarboro SB, Taddei PJ, Krishnan S, Kry SF, Newhauser WD. Methodology for determining doses to in-field, out-of-field and partially in-field organs for late effects studies in photon radiotherapy. Phys Med Biol 55(23):7009-7023, 12/7/2010. e-Pub 11/12/2010. PMCID: PMC3001332.
25. Serago CF, Burmeister JW, Dunscombe PB, Gale AA, Hendee WR, Kry SF, Wuu CS. Recommended ethics curriculum for medical physics graduate and residency programs. Report of Task Group 159. Med Phys 37(8):4495-4500, 8/2010. PMID: 20879608.
26. Wang Z, Howell RM, Burgett EA, Kry SF, Hertel NE, Salehpour M. Calibration of indium response functions in an Au-In-BSE system up to 800 MeV. Radiat Prot Dosimetry 139(4):565-573, 6/2010. e-Pub 12/15/2009. PMCID: PMC2909792.
27. Kry SF, Vassiliev ON, Mohan R. Out-of-field photon dose following removal of the flattening filter from a medical accelerator. Phys Med Biol 55(8):2155-2166, 4/21/2010. e-Pub 3/19/2010. PMID: 20305334.
28. Price MJ, Kry SF, Eifel PJ, Salehpour M, Mourtada F. Dose perturbation due to the polysulfone cap surrounding a Fletcher-Williamson colpostat. J Appl Clin Med Phys 11(1):3146, 2010. e-Pub 1/28/2010. PMID: 20160700.
29. Howell RM, Kry SF, Burgett E, Followill D, Hertel NE. Effects of tertiary MLC configuration on secondary neutron spectra from 18-MV x-ray beams for the Varian 21 EX linear accelerator. Med Phys 36(9):4039-4046, 9/2009. PMCID: PMC2738743.
30. Howell RM, Kry SF, Burgett E, Hertel NE, Followill DS. Secondary neutron spectra from modern Varian, Siemens, and Elekta linacs with multileaf collimators. Med Phys 36(9):4027-4038, 9/2009. PMCID: PMC2738742.
31. Kry SF, Salehpour M, Titt U, White RA, Stovall M, Followill D. Monte Carlo study shows no significant difference in second cancer risk between 6- and 18-MV intensity-modulated radiation therapy. Radiother Oncol 91(1):132-7, 4/2009. e-Pub 1/13/2009. PMID: 19147246.
32. Kry SF, Howell RM, Salehpour M, Followill DS. Neutron spectra and dose equivalents calculated in tissue for high-energy radiation therapy. Med Phys 36(4):1244-1250, 4/2009. PMCID: PMC2736753.
33. Kry SF, Howell RM, Polf J, Mohan R, Vassiliev ON. Treatment vault shielding for a flattening filter free medical linear accelerator. Phys Med Biol 54(5):1265-1273, 3/7/2009. e-Pub 2/3/2009. PMID: 19190359.
34. Wang Z, Howell RM, Kry SF, Burgett EA, Hertel NE, Salehpour MN. Characterization of a gold-and-indium dual-activation-foil-based bonner sphere system. Nuclear Technology 168:603-609, 2009.
35. Wang Z, Kry SF, Howell RM, Salehpour M. Comparison of unfolding methods for determining neutron spectrum and ambient dose equivalent. Nuclear Technology 168:610-614, 2009.
36. Kry SF, Price M, Wang Z, Mourtada F, Salehpour M. Investigation into the Use of a MOSFET Dosimeter as an Implantable Fiducial Marker. J Appl Clin Med Phys 10(1):22-32, 2009. PMID: 19223838.
37. Howell RM, Burgett E, Hertel NE, Kry SF, Wang Z, Salehpour M. Measurement of high-energy neutron spectra with Bonner Extension (BSE) system. Nuclear Technology 168:333-339, 2009.
38. Vassiliev ON, Kry SF, Chang JY, Balter PA, Titt U, Mohan R. Stereotactic radiotherapy for lung cancer using a flattening filter free Clinac. J Appl Clin Med Phys 10(1):2880, 2009. PMID: 19223837.
39. Johnson J, Nelson R, Hickman V, Kry SF. The cover up: skin dose increase during external beam therapy. Radiation Therapist 18:9-12, 2009.
40. Kry SF, Howell RM, Titt U, Salehpour M, Mohan R, Vassiliev ON. Energy Spectra, Sources, and Shielding Considerations for Neutrons Generated by a Flattening Filter-Free Clinac. Med Phys 35(5):1906-1911, 5/2008. PMID: 18561666.
41. Kry SF, Titt U, Followill D, Pönisch F, Vassiliev ON, White RA, Stovall M, Salehpour M. A Monte Carlo model for out-of-field dose calculation from high-energy photon therapy. Med Phys 34(9):3489-99, 9/2007. PMID: 17926952.
42. Vassiliev ON, Kry SF, Kuban DA, Salehpour M, Mohan R, Titt U. Treatment-planning study of prostate cancer intensity-modulated radiotherapy with a Varian Clinac operated without a flattening filter. Int J Radiat Oncol Biol Phys 68(5):1567-71, 8/2007. e-Pub 6/2007. PMID: 17544596.
43. Kry SF, Followill D, White RA, Stovall M, Kuban DA, Salehpour M. Uncertainty of calculated risk estimates for secondary malignancies after radiotherapy. Int J Radiat Oncol Biol Phys 68(4):1265-71, 7/2007. PMID: 17637398.
44. Kry SF, Starkschall G, Antolak JA, Salehpour M. Evaluation of the Accuracy of Fetal Dose Estimates Using TG-36 Data. Med Phys 34(4):1193-1197, 2007. PMID: 17500450.
45. Vassiliev ON, Titt U, Kry SF, Mohan R, Gillin MT. Radiation safety survey on a flattening filter-free medical accelerator. Radiat Prot Dosimetry 124(2):187-90, 2007. e-Pub 8/6/2007. PMID: 17681966.
46. Kry SF, Titt U, Poenisch F, Vassiliev ON, Salehpour M, Gillin M, Mohan R. Reduced Neutron Production Through Use of a Flattening Filter Free Accelerator. Int J Radiat Oncol Biol Phys 68(4):1260-1264, 2007. PMID: 17637397.
47. Kry SF, Price MJ, Followill D, Mourtada F, Salehpour M. The Use of LiF (TLD-100) as an Out-of Field Dosimeter. J Appl Clin Med Phys 8(4):169-175, 2007. PMID: 18449155.
48. Kry SF, Titt U, Poenisch F, Followill D, Vassiliev ON, White RA, Mohan R, Salehpour M. A Monte Carlo Model for Calculating Out-of-Field Dose from a Varian 6-MV Beam. Med Phys 33(11):4405-4413, 2006. PMID: 17153419.
49. Vassiliev ON, Titt U, Poenisch F, Kry SF, Mohan R, Gillin MT. Dosimetric Properties of Photon Beams From a Flattening Filter Free Clinical Accelerator. Phys Med Biol 51(7):1907-1917, 2006. e-Pub 3/2006. PMID: 16552113.
50. Ponisch F, Titt U, Kry SF, Vassiliev ON. MCNPX Simulation of a Multileaf Collimator. Med Phys 33(2):402-404, 2006. PMID: 16532947.
51. Titt U, Vassiliev ON, Ponisch F, Kry SF, Mohan R. Monte Carlo Study of Backscatter in a Flattening Filter Free Clinical Accelerator. Med Phys 33(9):3270-3273, 2006. PMID: 17022221.
52. Vassiliev ON, Titt U, Kry SF, Ponisch F, Gillin MT, Mohan R. Monte Carlo Study of Photon Fields from a Flattening Filter Free Clinical Accelerator. Med Phys 33(4):820-827, 2006. PMID: 16696457.
53. Ponisch F, Titt U, Vassiliev ON, Kry SF, Mohan R. Properties of Unflattened Photon Beams Shaped by a Multi Leaf Collimator. Med Phys 33(6):1738-1746, 2006. PMID: 16872081.
54. Kry SF, Salehpour M, Followill DS, Stovall M, Kuban DA, White RA, Rosen II. The calculated risk of fatal secondary malignancies from intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 62(4):1195-203, 7/2005. PMID: 15990025.
55. Kry SF, Salehpour M, Followill D, Stovall M, Kuban D, White RA, Rose I. Out of Field Photon and Neutron Dose Equivalents from Step and Shoot Intensity Modulated Radiation Therapy. Int J Radiat Oncol Biol Phys 62(4)(4):1204-1216, 2005. PMID: 15990026.
56. Followill D, Stovall M, Kry SF, Ibbott G. Neutron Source Strength Measurements for Varian, Siemens, Elekta, and General Electric Linear Accelerators. J Appl Clin Med Phys 4(3):189-194, 2003. PMID: 12841788.
57. Suprunowicz R, Butler RM, Ford COK, Kry SF. An Experimental Investigation of Convergent Flow to Horizontal Wells. Jour of Canadian Petroleum Technology 37(10):51-57, 1998.

Editorials

1. Kry SF, Howell RM. Invited commentary: Breast Disease: A year book quarterly. commentary on: Berrington de Gonzalez et al., Second solid cancers after radiotherapy for breast cancer in SEER cancer registries. Br J Cancer 102:220-226, 2009.
2. Howell RM, Kry SF. Invited commentary: Breast Disease: A year book quarterly. Commentary on: Inskip et al., Radiation dose and breast cancer risk in the childhood cancer survivor study. J Clin Oncol 27:3901-3907, 2009.
3. Kry SF, Howell RM. Invited commentary: Breast Disease: A year book quarterly. Commentary on: Mery et al., Second sarcomas after radiotherapy for breast cancer: sustained risk and poor survival. Cancer 115:4055-4063, 2009.
4. Howell RM, Kry SF, Stovall M. Invited commentary: Breast Disease: A year book quarterly. Commentary on: Yadav et al., Nonbreast second malignancies after treatment of primary breast cancer. Int J Radiat Oncol Biol Phys 73:1489-1492, 2009.
Other Articles
1. Yu J, Straube W, Mayo C, Giaddui T, Bosch W, Ulin K, Kry SF, Galvin J, Xiao Y. Radiation therapy digital submission process for national clinical trials network. Int J Radiat Oncol Biol Phys 90(2). e-Pub 2014.

Abstracts

1. Kerns J, Childress NL, Kry SF. A multi-institutional evaluation of multileaf collimator performance. Med Phys 40:445, 2013.
2. Kry SF. A Report On Flattening Filter Free C-Arm Linear Accelerators From the Therapy Emerging Technology Assessment Work Group. Med Phys 40:516, 2013.
3. McKenzie E, Balter P, Jones J, Followill DS, Stingo F, Pulliam K, Kry SF. Evaluation of the sensitivities of patient specific IMRT QA dosimeters. Med Phys 40:240, 2013.
4. Hunter L, Stingo F, Kry SF, Martel M, Choi H, Court LE. Identification of High Quality Machine-Robust CT Image Features. Med Phys 40:424, 2013.
5. Tonigan J, Kry SF, Balter P, Faught A, Followill DS. IMRT severity scoring for TG-100: do you really know? 40:418, 2013.
6. Kry SF, Molineu A, Alvarez P, Faught A, Huang J, Kerns J, Pulliam K, Tonigan J, Followill DS. In-house IMRT QA versus external phantom audit results. Med Phys 40:444, 2013.
7. Howell RM, Kry SF, Titt U. Project-based learning – expanding course content with a broad-scope project. Med Phys 40:413, 2013.
8. Pulliam K, Followill D, Dong L, Gilling M, Prado K, Kry S. An analysis of 13000 patient specific IMRT QA results from 13 different clinical treatment services. Med Phys 39:3866, 2012.
9. Huang J, Childress N, Kry SF. Calculation of high resolution and material specific photon energy deposition kernels. Med Phys 39:3822, 2012.
10. Faught A, Kry SF, Luo D, Molineu A, Bellezza D, Gerber R, Davidson S, Followill DS. Design, development and evaluation of a modified anthropomorphic head quality assurance phantom for use in stereotactic radiosurgery. Med Phys 39:3746, 2012.
11. Bergene J, Kry S, Molineu A, Bellezza D, Alvarez P, Johnson V, Followill DS. Development and implementation of the use of optimcally stimulated luminescent detectors in the radiological physics center anthropomorphic quality assurance phantoms. Med Phys 39:3722, 2012.
12. Repchak R, Molineu A, Popple R, Kry S, Howell R, Followill DS. Evaluation of the Anisotropic Analytical Algorithm heterogeneity correction dose calculation in flattened and flattening filter free beams for high energy x-ray beams using the radiological physics center Lung phantom. Med Phys 39:3807, 2012.
13. Lowenstein J, Kry SF, Molineu A, Alvarez P, Aguirre J, Summers P, Followill DS. High-energy photon standard dosimetry data: a quality assurance tool. Med Phys 39:3754, 2012.
14. Scarboro S, Cody D, Followill DS, Alvarez A, McNitt-Gray M, Zhang D, Kry S. Investigation of a commercial OSLD system for CT dosimetry. Med Phys 39:3807, 2012.
15. Kry S, Howell R. Second Cancers from radiation therapy procedures. Med Phys 39:3746, 2012.
16. Huang J, Pulliam K, Followill DS, Kry S. The effects of image resolution and noise on the gamma dose distribution comparison method for IMRT QA. Med Phys 39:3712, 2012.
17. Tonigan J, Kry S, Summers P, Balter P, Diel T, Followill DS. The magnitude of H&N IMRT dose delivery errors from three possible failure modes: beam quality, symmetry, and MLC position. Med Phys 39:3999, 2012.
18. Followill DS, Lowenstein J, Molineu A, Alvarez P, Aguirre J, Kry SF, Ibbott G. The Radiological Physics Center’s quality audit program: where can we improve?. Med Phys 39:3866, 2012.
19. Vredevoogd K, Ibbott G, Gillin M, Sahoo N, Kry S, Gifford K, Maryanski M. Three dimensional measurements of dose and LET from a proton beam via polymer gel dosimetry. Med Phys 39:3726, 2012.
20. Tucker S, Gomez D, Liao Z, Zhang L, Kry S, Martel M, Dong L. A novel technique to use CT images for in vivo detection and quantification of the spatial distribution of radiation-induced damage to the esophagus. Med Phys 38:3742, 2011.
21. Kerns J, Kry SF, Sahoo N, Followill D, Ibbott G. Angular dependence of the nanodot dosimeter. Med Phys 38:3517, 2011.
22. Joy S, Balter P, Starkschall G, Kry S, Salehpour M. Assessment of collimator jaw optimization in reducing normal tissue irradiation with intensity modulated radiation therapy. Med Phys 38:3689, 2011.
23. Pulliam K, Howell RM, Followill D, Luo D, White R, Kry SF. Clinical impact of couch top and couch rails on treatment dose for IMRT and Arc therapy. Med Phys 38:3592, 2011.
24. Faught A, Kry SF, Luo D, Molineu A, Galvin J, Drzymala R, Timmerman R. Design, development, and evaluation of a modified anthropomorphic head and neck quality assurance phantom for use in stereotactic radiosurgery. Med Phys 38:3526, 2011.
25. Niedzielski J, Kry SF. Development and testing of a single exposure film calibration procedure. Med Phys 38:3525, 2011.
26. Jones J, Childress N, Kry S. Development of a modified Winston-lutz test for evaluating errors in IGRT based setups. Med Phys 38:3505, 2011.
27. Tonigan J, Kry SF, Dong L, Purdie T, White R, Ibbott G, Followill DS. Does IMRT treatment plan complexity or mismatched dosimetry data contribute to dose delivery errors detected using an IMRT H&N quality assurance phantom?. Med Phys 38:3804, 2011.
28. Randeniya S, Mirkovic D, Kry S, Titt U, Newhauser W, Howell R. Patient specific out of field dose calculation tool for 6MV and 18MV: development and validation. Med Phys 38:3736, 2011.
29. Kerns J, Kry S, Sahoo N. Proton characteristiscs of the nanodot dosimeter. Med Phys 38:3507, 2011.
30. Neubauer E, Dong L, Followill D, Garden A, White RA, Kry SF. The Effect of should variation on IMRT and SmartArc plans for head and neck cancer. Med Phys 38:3474, 2011.
31. Scarboro S, Followill D, Kerns J, Kry SF. The impact of 6MV non-reference photon energy spectra on OSLD response. Med Phys 38:3726, 2011.
32. Davidson S, Kry S, Cui J, Deasy J, Ibbott G Vicic M White R, Followill DS. A Custom-Developed Method for Accurate Dose Recalculation of Patient Plans Entered into Clinical Trials. Med Phys 37(7):2372, 2010.
33. Kerns J, Ibbott G, Johnson V, Kry S, Sahoo N, Followill DS. Characterization of Optically-Stimulated Luminescent Detectors (OSLDs) in Photon and Proton Beams. Med Phys 37(7):3452, 2010.
34. Kisling K, Yaldo D, Followill DS, Kry S, Scarboro S, Frank S, Howell R. Evaluation of RapidArc Dose Delivery Using Radiological Physics Center Phantoms. Med Phys 37(7):2338, 2010.
35. Yaldo D, Tailor R, Scarboro S, Sahoo N, Kry S, Kisling K, Followill DS, Howell R. Evaluation of the Sensitivity of the Anisotropic Analytical Algorithm (AAA) to the Commissioning Dataset. Med Phys 37(7):3255, 2010.
36. Scarboro S, Kry S, Howell R, Followill DS. Variations in 6MV Photon Energy Spectra Impact the Response of TLD. Med Phys 37(7):3330, 2010.

Book Chapters

1. Howell RM, Kry SF. Modulated Arc Therapy Planning. In: Radiation Therapy Physics. Ed(s) Anders Brahme. Elsevier Ltd. Oxford, UK. In Press.
2. Benedict SH, Goetsch S, Perks J, Wijesooriya K, Mifton M, Vinogradskiy Y, Medin P, Desovich Y, Lovelock MD, Low DA, Kry SF. Stereotactic Radiation Therapy. In: Radiation Therapy Physics. Ed(s) Anders Brahme. Elsevier Ltd. Oxford, UK. In Press.
3. Biggs P, Kry SF. Monte Carlo for shielding of radiotherapy facilities. In: Monte Carlo Techniques in Radiation Therapy. Taylor & Francis, 2013.

Letters to the Editor

1. Kry SF, Olch A, Mohan R. Comment on “Monte Carlo evaluations of the absorbed dose and quality dependence of Al2O3 in radiotherapy photon beams”. Med Phys 42. e-Pub 2015.
2. Followill DS, Kry SF. Response to Thomsen et al: comments on "The Radiological Physics Center's standard dataset for small field size output factors". J Appl Clin Med Phys 15(2). e-Pub 2014.
3. Kry SF, Salehpour M,. In response to Dr. Schneider. Int J Radiat Oncol Biol Phys 64:1290-1291, 2006.

Grant & Contract Support

Title: 10% Personalized Dosimetry for Post Mastectomy Radiation Therapy, PA-13-169
Funding Source: NIH/NCI
Role: Co-Investigator
Principal Investigator: Howell
Duration: 8/1/2016 - 7/30/2019
 
Title: Improving tumor coverage in lung SBRT through the use of FFF beams.
Funding Source: Varian Medical Systems
Role: Co-Investigator
Duration: 3/1/2016
 
Title: Medical Physics Peer-Review
Funding Source: US Oncology
Role: Principal Investigator
Duration: 1/1/2015 - 12/31/2017
 
Title: Ensuring accurate and consistent radiation doses between MD Anderson Sister Institutions for clinical trials using proton therapy
Funding Source: University of Texas MD Anderson Sister Institution Network Fund
Role: Principal Investigator
Duration: 1/1/2015
 
Title: Improving radiation therapy by generating reference data
Funding Source: Mike Hogg Fund Application
Role: Principal Investigator
Duration: 1/1/2015
 
Title: Metal Artifact Reduction in Radiation Oncology
Funding Source: Mobius Medical Systems LLP
Role: Principal Investigator
Duration: 1/1/2015
 
Title: 25%, Impact of Contemporary Radiation Therapy on Second Breast Cancers in Pediatric Patients, PA-11-260
Funding Source: NIH/NCI
Role: Co-Principal Investigator
Principal Investigator: Howell
Duration: 4/1/2014 - 3/31/2017
 
Title: Imaging and Radiation Oncology Core (IROC) Group
Funding Source: NIH/NCI
Role: Co-Investigator
Principal Investigator: Followill
Duration: 3/1/2014 - 2/28/2019
 
Title: A Randomized Phase III Clinical Trial of Weekly versus Tri-weekly Cisplatin based Chemoradiation in Locally Advanced Cervical Cancer. Korean Gynecological Oncology Group
Funding Source: Radiotherapy quality assurance for the TACO trial
Role: Principal Investigator
Duration: 7/1/2013 - 7/1/2017
 
Title: CT dosimetry with nanoDot OLSD
Funding Source: Laundauer Inc.
Role: Principal Investigator
Duration: 6/1/2013
 
Title: Radiological Physics Center
Funding Source: NIH/NCI
Role: Co-Investigator
Principal Investigator: Followill
Duration: 1/1/2011 - 12/31/2014
 
Title: Late Effects Following Radiotherapy
Funding Source: UT MD Anderson Cancer Center Start Up Funds
Role: Principal Investigator
Duration: 1/1/2011 - 1/1/2014
 
Title: Phantom Measurements and Validation of High-Dose DVS
Funding Source: Sicel
Role: Principal Investigator
Duration: 12/1/2007 - 1/31/2008

Last updated: 1/20/2016